West Pharmaceutical Services, Inc. (WST)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in West Pharmaceutical Services, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

West Pharmaceutical Services, Inc. (WST) has returned -8.82% so far this year and 12.35% over the past 12 months. Looking at the last ten years, WST has achieved an annualized return of 13.95%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Jan 5, 1988, WST's average daily return is +0.06%, while the average monthly return is +1.19%. At this rate, your investment would double in approximately 4.9 years.

Historically, 59% of months were positive and 41% were negative. The best month was Apr 2020 with a return of +24.4%, while the worst month was Sep 2004 at -47.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.

On a daily basis, WST closed higher 46% of trading days. The best single day was Jul 24, 2025 with a return of +22.8%, while the worst single day was Sep 30, 2004 at -49.3%.

West Pharmaceutical Services, Inc. has an annualized alpha of 8.85%, beta of 0.64, and R² of 0.15 versus S&P 500 Index. Calculated based on daily prices since January 06, 1988.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (86.06%) than losses (73.86%) — typical of diversified or defensive assets.
• Beta of 0.64 may look defensive, but with R² of 0.15 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.15 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

WST ranks 51 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and compare them to a chosen benchmark (S&P 500 Index).

West Pharmaceutical Services, Inc. provided a 0.34% dividend yield over the last twelve months, with an annual payout of $0.86 per share. The company has been increasing its dividends for 20 consecutive years.

The table displays the monthly dividend distributions for West Pharmaceutical Services, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the West Pharmaceutical Services, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the West Pharmaceutical Services, Inc. was 59.29%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current West Pharmaceutical Services, Inc. drawdown is 46.22%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of West Pharmaceutical Services, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how West Pharmaceutical Services, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.